Voriconazole-a new therapeutic agent with an extended spectrum of antifungal activity.

Fulltext:
59076.pdf
Embargo:
until further notice
Size:
160.4Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2004Source
Clinical Microbiology and Infection, 10 Suppl 1, 1, (2004), pp. 107-17ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Haematology
Blood Transfusion and Transplantation Immunology
Journal title
Clinical Microbiology and Infection
Volume
vol. 10 Suppl 1
Issue
iss. 1
Page start
p. 107
Page end
p. 17
Subject
UMCN 1.5: Interventional oncologyAbstract
Voriconazole is a new antifungal agent that can be given orally and intravenously. It has proven efficacy for treating candidosis and invasive aspergillosis as well as other mould infections, such as those caused by Fusarium and Scedosporium spp. The drug is generally well tolerated.
This item appears in the following Collection(s)
- Academic publications [227587]
- Electronic publications [108623]
- Faculty of Medical Sciences [87012]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.